Hydroxychloroquine and Covid-19: A Cellular and Molecular Biology Based Update

21Citations
Citations of this article
122Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

As the time for finding a definitive and safe cure as a vaccine for novel Corona Virus Disease 2019 (Covid-19) is still far, there is need to study in depth about the other potential drugs, which can save millions of lives due to Covid-19 pandemic. Right at the center of the debate is the use of drug “Hydroxychloroquine” as a prophylaxis as well as a treatment strategy against Covid-19 in conjunction with azithromycin. In this review, we will study the cellular and molecular aspects of hydroxychloroquine, which had driven its use in Covid-19 patients, as well as its chemistry and pharmacokinetics along with clinical trials going on worldwide using hydroxychloroquine against Covid-19.

Cite

CITATION STYLE

APA

Pal, A., Pawar, A., Goswami, K., Sharma, P., & Prasad, R. (2020, July 1). Hydroxychloroquine and Covid-19: A Cellular and Molecular Biology Based Update. Indian Journal of Clinical Biochemistry. Springer. https://doi.org/10.1007/s12291-020-00900-x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free